4th Quarter - Termination

MERCURY PUBLIC AFFAIRS, LLC for KYTHERA BIOPHARMACEUTICALS, INC

Firm
Client
Income
$40,000
Expenses
—
Terminated
Dec 31, 2013

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Pharmaceutical compounding. S. 959, Pharmaceutical Quality, Security, and Accountability Act; H. R. 3204, Drug Quality and Security Act.

LobbyistCovered position, as disclosed
ALAN ELIAS —
ED KUTLER —
ERICK C. MULLEN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3204 (113th), S. 959 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.